Risks associated with the use of intravenous immunoglobulin 1 1This review article reflects the opinions of the authors and not necessarily those of the U.S. Food and Drug Administration.
Year: 2003
Type: review
Source: Transfusion Medicine Reviews
Authors: L.Ross Pierce, Nisha Jain
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: intravenous immunoglobulin, adverse events, drug safety, post-marketing surveillance, renal adverse effects, cardiovascular adverse events, central nervous system adverse events, infusion reactions, patient selection, risk-benefit assessment, infusion rate, pharmaceutical excipients, lot-to-lot variation
Open Access status: closed
OpenAlex ID: W2992089985
